Literature DB >> 18379117

Improvement of HPMC tablet disintegration by the addition of inorganic salts.

Atsushi Kajiyama1, Hirokazu Takagi, Kunikazu Moribe, Keiji Yamamoto.   

Abstract

Effects of inorganic salts on disintegration of hydroxypropylmethylcellulose (HPMC) matrix tablets have been studied. Adding disintegrants, such as Ac-di-sol, Primojel, Kolidon-CL, or low substituted hydroxypropylcellulose (L-HPC) to HPMC matrix tablets had no effect on disintegration property. Disintegration time was improved by adding NaHCO(3), KH(2)PO(4), K(2)SO(4), KCl, or NaCl to the HPMC tablets as tablet components. On the other hand, addition of Na(2)CO(3), or Na(2)SO(4) to the tablets showed no improvement of disintegration. The heat of dissolution of inorganic salts that improved disintegration of tablets was endothermic, while that of inorganic salts that did not improve disintegration of tablets was exothermic. These results suggested that the thermal environment and ionic strength inside the tablet might affect the disintegration of HPMC matrix tablets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379117     DOI: 10.1248/cpb.56.598

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  A novel beads-based dissolution method for the in vitro evaluation of extended release HPMC matrix tablets and the correlation with the in vivo data.

Authors:  Uroš Klančar; Boštjan Markun; Saša Baumgartner; Igor Legen
Journal:  AAPS J       Date:  2012-11-28       Impact factor: 4.009

2.  Sublingual Delivery of Frovatriptan: An Indication of Potential Alternative Route.

Authors:  Hitesh Verma; Surajpal Verma; Shyam Baboo Prasad; Harmanpreet Singh
Journal:  Int Sch Res Notices       Date:  2014-10-29

3.  A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets.

Authors:  Deanna M Mudie; Stephanie Buchanan; Aaron M Stewart; Adam Smith; Kimberly B Shepard; Nishant Biswas; Derrick Marshall; Alyssa Ekdahl; Amanda Pluntze; Christopher D Craig; Michael M Morgen; John M Baumann; David T Vodak
Journal:  Int J Pharm X       Date:  2020-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.